advertisement
Journal of Ocular Pharmacology and Therapeutics 14
Showing records 1 to 14 | Display all abstracts in Journal of Ocular Pharmacology and Therapeutics56321 Ascorbic acid modulation of iron homeostasis and lysosomal function in trabecular meshwork cells
Xu P; Lin Y; Porter K; Liton PB
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 246-253
56170 Human trabecular meshwork cells exhibit several characteristics of, but are distinct from, adipose-derived mesenchymal stem cells
Morgan JT; Wood JA; Walker NJ; Raghunathan VK; Borjesson DL; Murphy CJ; Russell P
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 254-266
56411 Differential expression of genes in cells cultured from juxtacanalicular trabecular meshwork and Schlemm's canal
O'Brien ET; Wang Y; Ying H; Yue BY
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 291-299
56169 Interleukin-20 receptor expression in the trabecular meshwork and its implication in glaucoma
Keller KE; Yang YF; Sun YY; Sykes R; Gaudette ND; Samples JR; Acott TS; Wirtz MK
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 267-276
56346 The effects of myocilin expression on functionally relevant trabecular meshwork genes: a mini-review
Borrás T
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 202-212
56262 The role of TGF-β2 and bone morphogenetic proteins in the trabecular meshwork and glaucoma
Wordinger RJ; Sharma T; Clark AF
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 154-162
56263 Tissue-based imaging model of human trabecular meshwork
Chu ER; Gonzalez JM; Tan JC
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 191-201
56174 Multi-scale analysis of segmental outflow patterns in human trabecular meshwork with changing intraocular pressure
Chang JY; Folz SJ; Laryea SN; Overby DR
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 213-223
56271 The microfibril hypothesis of glaucoma: implications for treatment of elevated intraocular pressure
Kuchtey J; Kuchtey RW
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 170-180
56100 Intraocular pressure homeostasis: maintaining balance in a high-pressure environment
Acott TS; Kelley MJ; Keller KE; Vranka JA; Abu-Hassan DW; Li X; Aga M; Bradley JM
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 94-101
56242 Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma
Jain A; Wordinger RJ; Yorio T; Clark AF
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 121-127
56363 Comparison of corneal safety and intraocular pressure-lowering effect of tafluprost ophthalmic solution with other prostaglandin ophthalmic solutions
Kumagami T; Wakiyama H; Kusano M; Kajiyama A; Miura Y; Uematsu M; Yoneda A; Kurihara J; Suzuma K; Kitaoka T
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 340-345
56362 The prostaglandin f2α analog fluprostenol attenuates the fibrotic effects of connective tissue growth factor on human trabecular meshwork cells
Fuchshofer R; Kuespert S; Junglas B; Tamm ER
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 237-245
56259 Application of canaloplasty in glaucoma gene therapy: where are we?
Aktas Z; Tian B; McDonald J; Yamamato R; Larsen C; Kiland J; Kaufman PL; Rasmussen CA
Journal of Ocular Pharmacology and Therapeutics 2014; 30: 277-282
